RSI low/high Values: [ 20 - 80 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of EIGR
Powered by GPT-4o
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

FAQ

What is the symbol for Eiger BioPharmaceuticals, Inc. Stock and on which exchange is it traded?
The symbol for Eiger BioPharmaceuticals, Inc. is EIGR and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Eiger BioPharmaceuticals, Inc. Stock?
Eiger BioPharmaceuticals, Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy Eiger BioPharmaceuticals, Inc. Stock?
Eiger BioPharmaceuticals, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Eiger BioPharmaceuticals, Inc. Stock.

What's the current price of Eiger BioPharmaceuticals, Inc. Stock?
As of the end of day on the Jul 03, 2024, the price of an Eiger BioPharmaceuticals, Inc. (EIGR) share was $1.73.

What is the 52-week high and low for Eiger BioPharmaceuticals, Inc. Stock?
The 52-week high for Eiger BioPharmaceuticals, Inc. Stock is $8.27 and the 52-week low is $0.200.

What is the market capitalization of Eiger BioPharmaceuticals, Inc. Stock?
As of the Jul 03, 2024, the market capitalization of Eiger BioPharmaceuticals, Inc. is 2.552M.

When is the next earnings date for Eiger BioPharmaceuticals, Inc.?
The upcoming earnings date for Eiger BioPharmaceuticals, Inc. is Aug 12, 2024.
Click to get the best stock tips daily for free!

About Eiger BioPharmaceuticals, Inc.

Eiger BioPharmaceuticals. Eiger BioPharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of targeted therapies for rare and ultra-rare diseases in the United States and internationally. Its lead product candidate is Lonafarnib, an orally bioavailable, small molecule, which is in Phase III clinical trials to treat hepatitis delta virus infection. The company's product candidate also include Lambda, which targe... EIGR Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT